Abstract
Major advances in our understanding of how the mammalian immune system recognises pathogens have evolved from initial observations of fruit-fly developmental mutants. Through this work it has been established that vertebrates possess a specialised ‘early warning system’ in the form of a panel of detectors to rapidly sense and trigger responses to the presence of microbial invaders through detection of so called pathogen-associated molecular patterns (PAMPs). This discovery has led to the search for new agonists and antagonists that can be used, therapeutically, for rational manipulation of the immune response. These efforts have already yielded several exciting new strategies to treat autoimmune, atopic, malignant and infectious disease. This review article provides an overview of the potential impact of these drugs on human medicine.
Keywords: interferon regulatory factor 3, chemokine receptor, Cytotoxic T lymphocyte, Toll-like Receptor, CpG toxicity, tumour necrosis factor
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Therapeutic Use of Molecules that Mimic Pathogen Danger Signals
Volume: 7 Issue: 3
Author(s): Jim E. Eyles
Affiliation:
Keywords: interferon regulatory factor 3, chemokine receptor, Cytotoxic T lymphocyte, Toll-like Receptor, CpG toxicity, tumour necrosis factor
Abstract: Major advances in our understanding of how the mammalian immune system recognises pathogens have evolved from initial observations of fruit-fly developmental mutants. Through this work it has been established that vertebrates possess a specialised ‘early warning system’ in the form of a panel of detectors to rapidly sense and trigger responses to the presence of microbial invaders through detection of so called pathogen-associated molecular patterns (PAMPs). This discovery has led to the search for new agonists and antagonists that can be used, therapeutically, for rational manipulation of the immune response. These efforts have already yielded several exciting new strategies to treat autoimmune, atopic, malignant and infectious disease. This review article provides an overview of the potential impact of these drugs on human medicine.
Export Options
About this article
Cite this article as:
Eyles E. Jim, Therapeutic Use of Molecules that Mimic Pathogen Danger Signals, Endocrine, Metabolic & Immune Disorders - Drug Targets 2007; 7 (3) . https://dx.doi.org/10.2174/187153007781662594
DOI https://dx.doi.org/10.2174/187153007781662594 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug
Current Diabetes Reviews Enhanced Gene Delivery and/or Efficacy by Functional Peptide and Protein
Current Topics in Medicinal Chemistry Current Biological Therapies for Inflammatory Bowel Disease
Current Pharmaceutical Design Retinoids as Differentiating Agents in Oncology: A Network of Interactions with Intracellular Pathways as the Basis for Rational Therapeutic Combinations
Current Pharmaceutical Design The Potential Use of Hormone-Based Therapeutics for the Treatment of Alzheimers Disease
Current Alzheimer Research Targeting Epigenome As An Innovative Pharmacological Strategy For Castration-resistant Prostate Cancer
Clinical Cancer Drugs Anticancer Drug Design Using Scaffolds of β-Lactams, Sulfonamides, Quinoline, Quinoxaline and Natural Products. Drugs Advances in Clinical Trials
Current Medicinal Chemistry Imidazoquinolines: Recent Developments in Anticancer Activity
Mini-Reviews in Medicinal Chemistry A Concise Update on the Relevance of Secretory Phospholipase A2 Group IIA and its Inhibitors with Cancer
Medicinal Chemistry Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment
Current Pharmaceutical Biotechnology Regulation of Endothelial Cell Death and Its Role in Angiogenesis and Vascular Regression
Current Neurovascular Research Kruppel-Like Factors 4 and 5: Unity in Diversity
Current Genomics Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Heparin Derivatives as Angiogenesis Inhibitors
Current Pharmaceutical Design Understanding Epithelial-Mesenchymal Transition may Reveal Novel Therapeutic Targets for Oral Squamous Cell Carcinoma
Current Cancer Therapy Reviews Activated Cancer Therapy Using Light and Ultrasound - A Case Series of Sonodynamic Photodynamic Therapy in 115 Patients Over a 4 Year Period
Current Drug Therapy An Overview of Phytotherapeutic Approaches for the Treatment of Benign Prostatic Hyperplasia
Mini-Reviews in Medicinal Chemistry Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
Current Drug Targets Recent Advances in the Synthesis and Development of Curcumin, its Combinations and Formulations and Curcumin-like Compounds as Anti-infective Agents
Current Medicinal Chemistry Statins and Cancer
Anti-Cancer Agents in Medicinal Chemistry